Mutation Ala393Thr of the MARS Gene: Clinical Trials

1 trial for Mutation Ala393Thr of the MARS Gene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Mutation Ala393Thr of the MARS Gene: new trials by email Literature Review of Mutation Ala393Thr of the MARS Gene trials Research Report on Mutation Ala393Thr of the MARS Gene

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
Methionine, Vitamin B12, B9, B6, C supplementation, Methionine/homocysteine Dosage - Pulmonary Alveolar Proteinosis, Mutation Ala393Thr of the MARS Gene
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris32019-09-162025-11-20

Narrower conditions

Pulmonary Alveolar Proteinosis (1)

Broader conditions

Lung Diseases (1)  ·  Respiratory Tract Diseases (1)

Interventions

Methionine (1)  ·  Vitamin B 12 (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)

Results publications

PMID 34503986

NIH funding

2018 (1)